Edward Lifesciences Corporation received its European CE Mark for the SAPIEN 3 Ultra, a new system for transcatheter aortic valve replacement.
The Edward SAPIEN 3 Ultra system is designed to help simplify and improve efficiency of procedures. It incorporates enhancements to the valve, which results in exceptional outcomes.
Read more at Edwards.
Image from Edwards